Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/609
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBotti, Mari-
dc.contributor.authorBeale, Elizabeth-
dc.contributor.authorCostello, Anthony-
dc.contributor.authorCrowe, Helen-
dc.contributor.otherWatts, Rosemary-
dc.date2007-09-
dc.date.accessioned2016-04-22T03:49:38Z-
dc.date.available2016-04-22T03:49:38Z-
dc.date.issued2009-04-
dc.identifier.citationInt J Nurs Stud. 2009 Apr;46(4):442-9.en_US
dc.identifier.issn0020-7489en_US
dc.identifier.issn1873-491Xen_US
dc.identifier.urihttp://hdl.handle.net/11434/609-
dc.description.abstractBACKGROUND: Robotic-assisted minimally invasive urologic surgery was developed to minimise surgical trauma resulting in quicker recovery. It has many potential benefits for patients with localised prostate cancer over traditional surgical techniques without taking a risk with the oncological result. OBJECTIVES: To report the specific surgical outcomes for the first Australian cohort of patients with localised prostate cancer that had undergone robotic-assisted radical prostatectomy (RARP) surgery. The outcomes represent the acute (in-hospital) recovery phase and include pain, length of stay (LOS), urinary catheter management and wound management. METHODS: Prospective descriptive survey of 214 consecutive patients admitted to a large metropolitan private hospital in Melbourne, Australia between December 2003 and June 2005. Patients had undergone RARP surgery for localised prostate cancer. Data were collected from the medical records and through interview at the time of discharge. Descriptive statistics were used to describe the frequency and proportion of outcomes. Patient characteristics were tabulated using cross tabulation frequency distribution and measures of central tendency. RESULTS: The findings from this study are highly encouraging when compared to outcomes associated with traditional surgical techniques. Transurethral catheter duration (median 7 days (IQ range 2)) and LOS (median 3 days (IQ range 2)) were considerably reduced. While operation time (median 3.30 h (IQ range 1.07)) was marginally reduced we would expect a further reduction as the surgical team becomes more skilled. CONCLUSION: The findings from this study contribute to building a comprehensive picture of patient outcomes in the acute (in-hospital) recovery phase for a cohort of Australian patients who have undergone RARP surgery for localised prostate cancer. As such, these findings will provide valuable information with which to plan care for patients' who undergo robotic-assisted surgery.en_US
dc.publisherElsevieren_US
dc.subjectProstatectomyen_US
dc.subjectUrologic Surgeryen_US
dc.subjectProstate Canceren_US
dc.subjectRoboticsen_US
dc.subjectRobotic-Assisted surgeryen_US
dc.subjectRobotic Assisted Radical Prostatectomyen_US
dc.subjectRARPen_US
dc.subjectMinimally Invasive Surgeryen_US
dc.subjectTreatment Outcomeen_US
dc.subjectAcute Recoveryen_US
dc.subjectLength of Stayen_US
dc.subjectTransurethral Catheter Durationen_US
dc.subjectCentre for Clinical Nursing Research, Epworth HealthCareen_US
dc.titlePatient outcomes in the acute recovery phase following robotic-assisted prostate surgery: a prospective study.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1016/j.ijnurstu.2007.07.010en_US
dc.identifier.journaltitleInternational Journal of Nursing Studiesen_US
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/17825304en_US
dc.description.affiliatesDepartment of Urology, University of Melbourne, Australiaen_US
dc.description.affiliatesDeakin University, Melbourne, Australiaen_US
dc.type.studyortrialProspective Studyen_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services
Epworth Prostate Centre
UroRenal, Vascular

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.